Epidemiology of leprosy in relation to control (WHO technical report series no. 716 of 1985). Part I.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000818:Animals; D000942:Antigens, Bacterial / Q000032:analysis; D001135:Armadillos; D002648:Child; D002980:Climate; D002991:Clofazimine / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D004197:Disease Reservoirs; D004359:Drug Therapy, Combination; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D000882:Haplorhini; D006801:Humans; D007223:Infant; D007918:Leprosy / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control / Q000635:transmission; D008297:Male; D008875:Middle Aged; D009166:Mycobacterium leprae / Q000187:drug effects / Q000254:growth & development / Q000276:immunology; D002679:Pan troglodytes; D012293:Rifampin / Q000627:therapeutic use; D012737:Sex Factors
D000942:Antigens, Bacterial; D003622:Dapsone; D002991:Clofazimine; D012293:Rifampin